Witthoeft T, Fuchs M, Ludwig D. Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study. World J Gastroenterol 2007; 13(4): 579-584 [PMID: 17278224 DOI: 10.3748/wjg.v13.i4.579]
Corresponding Author of This Article
Dr. Thomas Witthoeft, University Hospital Schleswig-Holstein Campus Luebeck, Dept. of Medicine I, Div. of Gastroenterology, Ratzeburger Allee 160, Luebeck 23538, Germany. witthoeft@uni-luebeck.de
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jan 28, 2007; 13(4): 579-584 Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579
Table 1 Demographic and clinical characteristics of 58 patients, n (%)
Characteristics
Mean age, years, (range)
36 (22–62)
Sex
Male
33
Female
25
Race
Caucasian
48 (100)
ALT, IU/L (range)
57 (9-263)
HCV-RNA level, > 800.000 IU/mL
23 (40)
Mean level, IU/mL
615.000
HCV genotype
1, 1a, 1b, 4
32 (55)
2a, 2b, 3
24 (42)
Not available
2 (3)
HCV genotype 1 and HCV-RNA > 800.000 IU/mL
19 (33)
Liver biopsy (available in 56 out of 58 patients)
No chronic hepatitis
10 (17)
Chronic hepatitis
43 (74)
Cirrhosis
3 (5)
Co-medication
Methadone
4 (7)
Codeine
7 (12)
Table 2 Sustained viralogical response by HCV genotype, gender and sex (wk 72), n (%)
All genotypes
< 800.000 IU/mL
23/33 (70)
≥ 800.000 IU/mL
13/25 (52)
Genotype 1
< 800.000 IU/mL
5/6 (83)
≥ 800.000 IU/mL
9/19 (47)
Non-genotype 1
< 800.000 IU/mL
18/27 (67)
≥ 800.000 IU/mL
4/6 (67)
Sex
Male
16/33 (49)
Female
14/25 (56)
Table 3 Frequency of laboratory abnormalities (n = 58)
Event
n
Neutropenia
< 1500
21
< 1000
10
< 500
1
Anemia
< 10.5 g
1
< 8.5 g
0
Platelets
< 100.000
4
< 50.000
0
Table 4 Questionnaire (Int. Quality of Life Assessment SF-36). Listed are those answers presenting the majority of possible answers (%)
wk 0
wk 12
Personal feeling
Very good (76)
Good (63)
Personal feeling compared to last week
Good (77)
Better (55)
Impaired physical activity
Never (90)
Slightly (77)
Impaired physical activity compared to last week
Never (88)
Slightly (73)
Emotional problems
Never (93)
Never (48)
Pain
None (90)
None (30)
Pain last week
None (83)
None (54)
Feeling depressed
Never (88)
Seldom (45)
Feeling happy
Often (85)
Sometimes (50)
Feeling tired
Seldom (77)
Sometimes (51)
Impaired personal contact to relatives and friends due to disease
Never (88)
Seldom (71)
“I’m feeling fit like others”
Mostly (94)
No (37)
“I’m feeling healthy”
Mostly (78)
No (65)
“I expect not to feel healthy”
Do not know (44)
No (32)
Citation: Witthoeft T, Fuchs M, Ludwig D. Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study. World J Gastroenterol 2007; 13(4): 579-584